JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carvalho, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carvalho, B.
Related Collections
Right arrow Obstetrics
Right arrow Regional Anesthesia
Right arrow Pain

Anesth Analg 2005;100:1150-1158
© 2005 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000149544.58230.FF


OBSTETRIC ANESTHESIA

Single-Dose, Sustained-Release Epidural Morphine in the Management of Postoperative Pain After Elective Cesarean Delivery: Results of a Multicenter Randomized Controlled Study

Brendan Carvalho, MBBCh, FRCA*, Edward Riley, MD*, Sheila E. Cohen, MBChB, FRCA*, David Gambling, MB, BS, FRCPC{dagger}, Craig Palmer, MD{ddagger}, H. Jane Huffnagle, DO§, Linda Polley, MD||, Holly Muir, MD, Scott Segal, MD#, Christine Lihou, CCRA**, Garen Manvelian, MD** for the DepoDur Study Group

*Department of Anesthesia, Stanford University School of Medicine, Stanford, California; {dagger}Sharp Mary Birch Hospital for Women, San Diego, California; {ddagger}Department of Anesthesiology, University of Arizona Health Sciences Center, Tucson, Arizona; §Department of Anesthesiology, Thomas Jefferson University, Philadelphia, Pennsylvania; ||Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, Michigan; ¶Department of Anesthesiology, Duke University, Durham, North Carolina; #Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital, Boston, Massachusetts; and **SkyePharma, Inc., San Diego, California

Address correspondence and reprint requests to Brendan Carvalho, MBBCh, FRCA, Department of Anesthesia, Stanford University School of Medicine, 300 Pasteur Dr., Stanford, CA 94305. Address e-mail to bcarvalho{at}stanford.edu.

In this multicenter, randomized, controlled study, we compared the analgesic efficacy and safety profile of a new single-dose extended-release epidural morphine (EREM) formulation (DepoDurTM) with that of epidural morphine sulfate for the management of postoperative pain for up to 48 h after elective cesarean delivery. ASA physical status I or II parturients (n = 75) were anesthetized with a combined spinal/epidural technique. Parturients received intrathecal bupivacaine 12–15 mg and fentanyl 10 µg for spinal anesthesia and a single epidural injection of either 5 mg of standard (conventional preservative-free) morphine or 5, 10, or 15 mg of extended-release morphine after cord clamping for postoperative pain control. Single-dose EREM 10 and 15 mg groups significantly decreased total supplemental opioid medication use and improved functional ability scores for 48 h after surgery compared with those receiving 5 mg of standard morphine. Visual analog scale pain scores at rest and with activity at 24 to 48 h after dosing were significantly better in the 10- and 15-mg single-dose EREM groups versus the standard morphine group. There were no significant differences between the two 5 mg (single-dose EREM and standard morphine) groups. Single-dose EREM was well tolerated, and most adverse events were mild to moderate in severity. Single-dose EREM is a potentially beneficial epidural analgesic for the management of post-cesarean delivery pain and has particular advantages over standard morphine for the period from 24 to 48 h after surgery.




This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
E. R. Viscusi, D. R. Gambling, T. L. Hughes, and G. Z. Manvelian
Pharmacokinetics of extended-release epidural morphine sulfate: Pooled analysis of six clinical studies
Am. J. Health Syst. Pharm., June 1, 2009; 66(11): 1020 - 1030.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
B. Carvalho
Respiratory Depression After Neuraxial Opioids in the Obstetric Setting
Anesth. Analg., September 1, 2008; 107(3): 956 - 961.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
B. Carvalho and E. Riley
Extended Release Epidural Morphine, Far from Ideal for Postcesarean Delivery Pain Control
Anesth. Analg., December 1, 2007; 105(6): 1864 - 1865.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
B. Carvalho, L. M. Roland, L. F. Chu, V. A. Campitelli III, and E. T. Riley
Single-Dose, Extended-Release Epidural Morphine (DepoDurTM) Compared to Conventional Epidural Morphine for Post-Cesarean Pain
Anesth. Analg., July 1, 2007; 105(1): 176 - 183.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
E. R. Viscusi
Emerging treatment modalities: Balancing efficacy and safety
Am. J. Health Syst. Pharm., March 15, 2007; 64(6_Supplement_4): S6 - S11.
[Abstract] [Full Text] [PDF]


Home page
J Am Board Fam MedHome page
R. Sinatra
Opioid Analgesics in Primary Care: Challenges and New Advances in the Management of Noncancer Pain
J Am Board Fam Med, March 1, 2006; 19(2): 165 - 177.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2005 by the International Anesthesia Research Society.